Speaker illustration

Doctor Herbert Himmel

Bayer AG, Wuppertal (Germany)

Lack of pro-arrhythmic potential for the novel soluble guanylate cyclase stimulator vericiguat: results from preclinical studies

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Chronic heart failure e-posters

Thumbnail

This platform is supported by

logo Novo Nordisk